sign reading "bio-security precautions, no unauthorized personnel"
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens
Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.
ABOVE: © ISTOCK.COM, STEPHEN BARNES
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens

Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.

Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.

ABOVE: © ISTOCK.COM, STEPHEN BARNES

MERS

close-up of empty vaccine vials in a factory
The Quest for a Universal Coronavirus Vaccine
Diana Kwon | Jun 29, 2021
Scientists are on the hunt for a shot that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future.
Contributors
The Scientist Staff | Jun 1, 2021
Meet some of the people featured in the June 2021 issue of The Scientist.
Opinion: Comparing Coronaviruses
Nicola Petrosillo | Jun 1, 2021
In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows
Max Kozlov | Nov 23, 2020
Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.
Human coronavirus discoveries
Timeline: Human Coronavirus Discoveries
Shawna Williams | Jun 4, 2020
Download our poster of the biggest milestones, from the discovery of the viral family in humans in the 1960s to the identification of SARS-CoV-2.
gold spots on a blue background
A Brief History of Human Coronaviruses
Shawna Williams | Jun 2, 2020
Milder, cold-causing members of this pathogenic viral family long remained under the radar, although they aren’t entirely harmless.
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Abby Olena | Mar 31, 2020
The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.
Lost Smell and Taste Hint COVID-19 Can Target the Nervous System
Ashley Yeager | Mar 24, 2020
The symptoms suggest SARS-CoV-2 might infect neurons, raising questions about whether there could be effects on the brain that play a role in patients’ deaths, but the data are preliminary.
Why Some COVID-19 Cases Are Worse than Others
Katarina Zimmer | Feb 24, 2020
Emerging data as well as knowledge from the SARS and MERS coronavirus outbreaks yield some clues as to why SARS-CoV-2 affects some people worse than others.
The Latest Drug Trials for Coronavirus
Ashley Yeager | Feb 18, 2020
Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.
Image of the Day: Coronavirus Under the Scope
Amy Schleunes | Feb 17, 2020
The National Institute of Allergy and Infectious Diseases releases a series of images that offer a close up look at the novel coronavirus SARS-CoV-2.
an illustration of cononaviruses
New Coronavirus Identified in Central China Pneumonia Outbreak
Shawna Williams | Jan 9, 2020
The virus, which has sickened at least 59 people, does not appear to transmit easily between humans.
Cause of Viral Pneumonia Outbreak in China Unknown
Catherine Offord | Jan 6, 2020
Health authorities have ruled out the usual suspects, leading to fears that a novel virus is causing the infections in Hubei Province.
Bats a Major Global Reservoir of Coronaviruses
Diana Kwon | Jun 12, 2017
Understanding the patterns of diversity in bat-hosted viruses may help researchers better predict when and where outbreaks may occur.
Experimental MERS Treatments Target Host Cell Receptor
Ashley Yeager | Mar 30, 2017
Researchers are searching for ways to prevent the coronavirus from attaching to DPP-4 receptors, blocking it from invading and replicating within host cells.
Non-Travel-Associated MERS in Kenya
Maina Waruru | Mar 23, 2016
Researchers report evidence of past Middle East respiratory syndrome coronavirus infection in two people in the country.
MERS Vax Tested in Camels
Anna Azvolinsky | Dec 17, 2015
Scientists conduct the first MERS-CoV vaccine trials in camels and provide viral lineage evidence of camel-to-human transfer.
mers coronavirus
Lab-Made Coronavirus Triggers Debate
Jef Akst | Nov 16, 2015
The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research.
Synthetic DNA–based MERS Vaccine Shows Promise
Anna Azvolinsky | Aug 19, 2015
The experimental vaccine protects monkeys against the coronavirus that causes Middle East respiratory syndrome and elicits an immune response in camels.